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Abstract 
Objectives and methods. In the framework of the EU-funded project “EU-Madness”, we collected 
and analysed all the reports of fatalities directly or indirectly related to substances of abuse reg-
istered in Ibiza from January to September 2015, in order to analyse the characteristics of the 
sample, the identified substances and the nature of deaths associated with their consumption. 
Results. A significant increase of substance-caused deaths with respect to the previous four 
years has been highlighted. Most of the subjects were young males, more than half were not Span-
ish. Males prevailed also among the victims of traffic accidents and suicides. The most commonly 
involved substances included MDMA, alcohol, cocaine, THC, opiates and prescription drugs. Con-
clusions. Although the use of NPS is rapidly increasing in Europe, according to the results from 
our sample, alcohol and well-known stimulants (MDMA and cocaine) are still the substances of 
abuse mainly involved in the cases of substance-caused and substance-related fatalities. The sig-
nificant increase of fatalities in Ibiza in the last 5 years is an issue that must be taken into account 
and should be better investigated, as other theories besides NPS increased diffusion should be 
proposed, and therefore targeted prevention strategies should be designed. 
 
 
  
3 
Introduction 
 
Illicit substance use is well known as an important contributor to the global burden of diseases; 
indeed, the extent of problem drug use in specific clinical settings such as psychiatric or emer-
gency units is not limited to subjects with substance use disorders (SUD) or dependence, but it 
also includes occasional recreational drug users (Degenhardt et al., 2013). The physical and psy-
chopathological risks of non-habitual substance consumption are frequently underestimated, 
and substance-related fatalities often involve first-time or sporadic clients. Moreover, in recent 
times, in addition to “classic” substances of abuse, Novel Psychoactive Substances (NPS) have 
emerged, determining a further health issue of growing importance. There is currently an increas-
ing body of clinical evidence to demonstrate the potential acute and chronic health harms associ-
ated with the use of NPS, but often very little is known by both consumers and health care profes-
sionals (Martinotti et al., 2015; Simonato et al., 2013). A number of NPS has been directly or indi-
rectly associated with serious adverse effects and fatalities: 2-DPMP and D2PM, two synthetic 
stimulants belonging to the class of piperidines, have shown both neuropsychiatric and cardio-
vascular toxicity, and they have been involved in three deaths in August 2010 (Corkery et al., 
2012). Misuse of gamma hydroxybutrate (GHB) and gamma butyrolactone (GBL) has been impli-
cated in more than 150 fatalities in the UK from 1995 to 2013 (Corkery et al., 2015), and more 
recently, stimulants mixes and synthetic cannabinoids have emerged as potentially life-threaten-
ing (Santacroce et al., 2014). NPS-related deaths have been investigated mainly in the UK 
(Chiappini et al., 2015; Loi et al., 2015; Corkery et al., 2011), but in this context, poly-substance 
use and behavioural risk taking seem to be particularly widespread in the Balearic Islands night-
life scene. Indeed, Majorca, Menorca, Ibiza and Formentera are among the most popular tourist 
destinations in the whole of Europe: such an international and representative nightlife resort ap-
pears as a crucial key setting to address substance-related health problems and fatalities. Previous 
research projects conducted in the Islands have addressed substance use and risky behaviours 
undertaken by young tourists and foreign casual workers (Bellis et al., 2009; Kelly et al., 2014), 
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highlighting that substance misuse and sexual risk taking are widespread between both catego-
ries. The growth in international travel associated with nightlife, the additional risks posed by 
clubbing in an unfamiliar country, the threats of new and often unknown psychoactive substances 
and the changes in substance use and risk-taking amongst people visiting an international resort 
mean that both interventions, and basic health and safety measures are now required on an inter-
national basis (Bellis et al., 2002; Bellis et al., 2000).  
In the framework of the EU-funded project “EU-Madness”, our goal was to focus on the records of 
all psychoactive substance-involving fatalities registered in Ibiza from January to September 
2015, in order to analyse the characteristics of the sample, the identified substances and the na-
ture of deaths associated with their consumption.  
 
Methods  
 
With the cooperation of the team of the Forensic Medicine Unit of Ibiza, coordinated by dr. Sancho 
Jaraiz, all the reports of fatalities directly related to drugs in 2015 were collected and tabulated in 
a dedicated database. A further addition regarded the collection of all the reports of fatalities that 
might involve psychoactive substance such as suicides and traffic accidents, for the same 
timeframe. When possible, comparison with data from 2011 to 2014 was performed. All reports 
included analysis of body samples (blood, urine, vitreous humour, bile) for both classic and novel 
substances of abuse. Sampled tissues were sent for specific analysis to the National Institute of 
Toxicology and Forensic Sciences in Barcelona. Headspace-gas chromatography (GC) with 
flame ionisation detection (FID) was used to detect the presence of ethanol in the 
specimens. To assess the consumption of psychoactive substances and/or prescription 
drugs, GC was combined to mass spectrometry (MS) (GC-MS). 
 
Results 
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From January to the end of September 2015, 12 fatalities directly related to substance misuse 
have been registered in Ibiza, which represents a significant increase with respect to the previous 
four years (three fatalities in 2014, four in 2013, five in 2012, and just one in 2011). 9 out of 12 
subjects were males (75%); mean age was 30.5 years, with the youngest deceased being two fe-
males, both 18 years old Britons (50% of the deceased subjects were British). Most of the victims 
(58.3%) were found dead in a hotel, while 25% died in his/hers own house, 8.3% in somebody 
else’s house, and the same percentage was pronounced dead in the local hospital.  Four subjects 
(33%) had a previous history of alcohol and substance abuse and/or psychiatric disorders (both 
in the mood spectrum). Most common causes of death were acute pulmonary oedema/haemor-
rhage, acute respiratory failure and multi-organ failure; one patient (8.3%) suffered multiple trau-
mas due to precipitation from height while intoxicated. A number of the collected samples of 
blood, bile, urine and vitreous humour still have to be analysed: the cases for which definitive 
results were already available (9 out of 12 – 75%) involved alcohol (6 cases - 66% of the cur-
rently available analyses), cocaine (5 cases, 55%), 3,4-Methylenedioxymethamphetamine 
- MDMA (4 cases – 44%), opiates (methadone, morphine and codeine, 3 cases, 33%) and a 
number of prescription drugs (3 cases, 33%, in which it has been evidenced a combination 
of trazodone, pregabalin, clonazepam, alprazolam, mirtazapine, corticosteroids and mac-
rolide antibiotics, plus one case in which was detected phenytoin). MDMA and alcohol were 
found in the vitreous humour of the one subject whose death was traumatic (ascertained cause: 
traumatic cardiac rupture, multiple trauma due to precipitation from a height). A synthesis of the 
results is provided in Table 1. 
 
- Insert Table 1 about here-  
 
From January to the end of September 2015, seven traffic accident-related fatalities were regis-
tered in Ibiza. Six out of seven deceased (85.7%) were males; the only female was an 81-year-old 
Spanish woman, victim of an intoxicated driver. More than half of the deceased were Spanish (4 
6 
out of seven, 57%), while the remaining were foreigners (from Philippines, Belgium and Mo-
rocco). In three cases (41.8%) the deceased was an intoxicated driver (alcohol, or alcohol and 
cocaine); in three other cases, the driver was intoxicated (cocaine and delta-9-tetrahydrocanna-
binol [THC]; alcohol, THC and amphetamines; alcohol and THC) but the victim was substance-
free (see Table 2 for a summary).  
 
- Insert Table 2 about here- 
 
From January to the end of September 2015, nine suicides were registered in Ibiza. Six out of nine 
victims were males (66.6%), mean age was 42.6 years old. Six again were Spanish, while the oth-
ers were two Britons and a French. Five subjects had a previous history of psychiatric disorders 
(mostly depression and anxiety disorders); three were in treatment with antidepressants and 
benzodiazepines. Cocaine was implicated in two of the suicides, but it was not the cause of death 
(one was hanging and the other jumping from height – see Table 3 for a summary). 
 
-Insert Table 3 about here- 
 
Discussion and conclusions 
 
According to the results from our sample, alcohol and stimulants (MDMA and cocaine) are the 
substances of abuse mainly involved in the cases of substance-caused and substance-related fa-
talities. A substance-caused fatality may be defined as a death in which the direct toxic effects of 
the psychochoactive caused or contributed to the death, while a substance-related fatality is a 
death in which the substance of abuse was demonstrated in the blood, but did not directly cause 
death (e.g., polytrauma for accidental precipitation). Again, alcohol is present in almost the totality 
of traffic accident-related deaths, followed by cocaine, THC and MDMA, and it is also one of the 
few substances detected in suicides, together with cocaine and prescription drugs. Alcohol is still 
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the most commonly abused psychoactive substance: according to the 2014 Global Drug Survey 
(GDS), which involved around 80,000 subjects in 18 countries, 90.8% of the interviewees had used 
alcohol in the 12 months before the survey (The Global Drug Survey, 2014). A recent epidemio-
logical research on more than 1,000 Italian young adults aged 18-26 highlighted that 80.5% of 
the sample habitually consumed alcoholic drinks, and almost 20% drank 5 or more units of alco-
hol per time (a unit of alcohol corresponds to a drink containing 12 grams of ethanol) more than 
once a week (Lupi et al., 2015). Moreover, a relevant subgroup (66.5%) admitted a binge-drinking 
pattern of alcohol consumption, with consistent psychophysical consequences (loss of control and 
consciousness, aggressive behaviour, hospitalisation, sexual disinhibition, need for prescription 
drugs after intoxication). Similar figures have been presented by the World Health Organization 
in its Information System on Alcohol and Health (World Health Organization, 2011), while the 
ESPAD survey, which is focused on a younger population (15- and 16-year-old students from 36 
European countries), evidenced a prevalence of alcohol consumption of 79% in the year before 
the survey, with a significant increase over the years for “heavy episodic drinking” (from a mean 
average of 29% in 1995 to 38% in 2011) (European School Survey Project on Alcohol and Other 
Drugs, 2012). Deaths related to alcohol intoxication occur most frequently if a large quantity of 
ethanol is ingested in a short timespan: this makes binge drinking and heavy episodic drinking 
extremely dangerous from a public health point of view. Data from the Vital Signs report of the US 
Center for Disease Control and Prevention (CDC) underline that there are more than 2,200 alcohol 
poisoning deaths in the US each year, with an average of 6 per day (Center for Disease Control and 
Prevention, 2015). Alcohol is frequently consumed together with other drugs: according to the 
gateway theory, it may also be considered as a “first step” before moving to different or harder 
substances. In the US, 69.9% of heavy alcohol users aged 12 to 17 are also illicit drug users. This 
is over 13 times higher than non-alcohol users, where 5.2% use illegal substances (National Insti-
tute for Drug Abuse, 2009). Poly-substance misuse may represent a notable increase in the risk of 
severe health consequences, including of course death. Alcohol may be associated with stimulants, 
or other central nervous system (CNS) depressors, and the pharmacological, toxicological and 
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psychopathological effects due to interactions among substances may be unpredictable and fatal 
in vulnerable individuals (Martinotti et al., 2009). Stimulants such as cocaine and MDMA, which 
are often reported in our sample, also account for a remarkable number of fatalities. With respect 
to Europe, cocaine use has the highest prevalence among young adults (15-34) in the UK (4.2%) 
and in Spain (3.3%); amphetamines figures appear to be lower, with the highest percentage of use 
in Estonia (2.5%), Germany (1.8%), and again UK (1.5%) and Spain (1.2%) (European Monitoring 
Centre for Drugs and Drug Addiction, 2015). Although use trends are increasing, data regarding 
the hazards of stimulants are limited. Cocaine appears to have played a determinant role in 1% to 
15% of drug-related deaths in countries that were able to differentiate between drug types deter-
mining fatalities (European Monitoring Centre for Drugs and Drug Addiction, 2005). According to 
a study revising cocaine and crack-cocaine deaths in the UK from January 1990 to December 2004, 
these substances were involved in a total of 1022 deaths, with a peak of 185 fatalities in 2004. 
Alcohol, either alone or in combination with other substances, was found in 21% of the cases. 
Cocaethylene, the ethyl ester of benzoylecgonine, is formed in vivo by liver esterases when co-
caine and ethanol coexist in the blood (Dean et al., 2001). Both ethanol and cocaethylene reduce 
mean cocaine clearance by 47% and 26%, respectively (Parker et al., 1996). Cocaine effects are 
therefore prolonged, and this may facilitate its role in poly-drug combination deaths. Cocaine con-
sumption is also peculiarly high among clubbers: a recent British research found that young peo-
ple (age 16–29) who visit nightclubs are more than twice as likely to use cocaine as non-club goers 
(e.g. last month use in 2005/6, 4.2% in club-goers vs. 1.6% in non-club goers) (Roe & Man, 2006). 
Amphetamines, on the other hand, belong to the chemical class of phenethylamines; they tend to 
be stimulants and/or hallucinogens and have some entactogenic properties, and in higher doses, 
they may induce euphoria, stronger feelings of self-esteem, but can also increase blood pressure, 
raise body temperature (hyperthermia), increase heart rate, and lead to acute brain damage 
(starting with memory loss) or even death due to stroke or cardiac arrest (Parrott & Lasky, 1998). 
MDMA has a strong connection with dance music culture, as it became the most popular drug in 
the mid-1980s in acid house parties and raves. Light shows, intense colours and high-pitch music 
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are in fact better appreciated due to the increased sensitivity and the pupil dilation caused by 
MDMA: Ibiza and its renowned discos represent therefore the ideal setting for ecstasy experi-
menting. According to Bellis et al., while visiting Ibiza, 7.2% of British tourists try MDMA for the 
first time, with similar percentages amongst Spanish (8.6%) but not Germans (1.8%) or those 
visiting Majorca (0.8, 1.5 and 1.2%, respectively) (Bellis et al., 2009). In the meantime, most indi-
viduals visiting Ibiza were already illicit drugs users in their home country, with nearly the totality 
of the subjects continuing to consume psychoactive substances in Ibiza. The “holiday” use of most 
drugs in the island appears to differ from the “home” pattern of consumption for the binge behav-
iour, with many individuals using drugs 5 or more nights per week (Bellis et al., 2003). Data from 
the UK np-SAD database (National Programme on Substance Abuse Deaths) covering the years 
1997-2007 reported 832 amphetamine/metamphetamine-related fatalities and 605 MDMA-re-
lated fatalities. In comparison with amphetamine/metamphetamine victims, the MDMA ones 
were more likely to be younger, less likely to be known as drug users and to have a suicidal intent 
(Schifano et al., 2010): these data match with our results as well, as MDMA was never identified 
in suicide victims but it was prevalent among young victims of accidental drug-caused fatalities.  
Although the use of NPS is rapidly increasing in Europe, with report of relevant psychopathologi-
cal consequences and fatalities, the use of alcohol, cocaine and “first generation” psychedelics still 
represent the main substances implicated in both direct and indirect deaths. The significant 
growth of drug-involving fatalities in Ibiza in the last 5 years is an issue that must be taken into 
account and should be better investigated. Indeed, if this trend is not determined by the direct use 
of the novel and highly toxic drugs, other theories should be proposed: 1) is there a wider “base” 
of substance misusers, with the subsequent exposition of more subjects which may be at higher 
risk for predisposing factors? (Duysen et al., 2008); 2) may the combination of different lifestyles 
and behaviours, such as polyabuse patterns, binge drinking, drunkorexia, intense physical activi-
ties during rave parties, be implicated? (Lupi et al., 2015; Martinotti et al., 2009); 3) are there 
chances that the research and exploration of the limits proposed online by psychonauts may be 
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becoming a trend in real life as well? All the above-mentioned considerations should be investi-
gated in further studies together with a careful monitoring of critic “hotspots” of substance mis-
use, in order to design better and targeted prevention strategies.  
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TABLES 
 
Table 1. Drug-related and drug-caused fatalities 2015 
 
Date 
of 
death 
Sex Age National-
ity 
Place 
of 
death 
Previous psychiatric 
or substance abuse 
history 
Ascer-
tained 
cause of 
death 
Detected  
substances 
02/06 M 26 UK H - Polytrauma Alcohol/MDMA 
08/06 M 31 UK H Substance abuse Shock; gas-
tric haemor-
rhage 
MDMA/cocaine/ 
alcohol/codeine 
12/06 F 24 GER H Substance abuse Acute resp 
failure; SNC 
depression 
Cocaine/ 
methadone 
15/06 M 21 UK H - Asphyxia  - 
15 
19/06 M 36 SPA Hou - Pulm acute 
oedema 
Alcohol/cocaine
/morphine/mCP
P/Prescription 
drugs (pregaba-
lin, alprazolam, 
clonazepam, 
levomeproma-
zine, mirtazap-
ine, trazodone) 
19/06 M 40 SPA Fr Hou - Pulm haem-
orrhage 
Alcohol/morphi
ne/prescription 
drugs (pregaba-
lin, alprazolam, 
clonazepam, 
levomeproma-
zine, mirtazap-
ine) 
23/06 M 33 SPA Hou - Acute resp 
failure 
Alcohol/cocaine 
06/07 M 41 Other H - Acute resp 
failure 
- 
21/07 M 23 UK H - Multi-organ 
failure 
Alcohol/MDMA/ 
cocaine 
28/07 M 55 SPA Hou Bipolar/alcohol and 
cocaine 
Pulm oe-
dema 
Cocaine/Phenyt
oin 
23/09 F 18 UK Hosp Depression Multi-organ 
failure 
MDMA 
29/09 F 18 UK H - Still un-
known 
- (broken plastic 
bag with white 
powder found in 
the stomach) 
 
 
 
 
Legend.  H=hotel; Hou= house; FrHou = Friends’ house; Hosp= hospital 
16 
 
 
 
 
 
Table 2. Traffic-related fatalities 2015 
 
Date of 
death 
Sex Age Nationality Driver/victim Detected substances (in 
driver) 
23/02 M 38 Belgian D Alcohol/cocaine 
14/04 F 81 SPA V Alcohol/THC 
04/05 M 37 Moroccan  V Alcohol/THC/MDMA 
20/05 M 48 Filipino V Cocaine/THC 
28/07 M 27 SPA D Alcohol 
31/08 M 23 SPA D Alcohol 
22/09 M 51 SPA D - 
 
 
 
 
Table 3. Suicides 2015 
Date of 
death 
Sex Age Nationality Previous psychiatric or 
substance abuse his-
tory 
Ascertained 
cause of death 
Detected  
substances  
10/01 F 46 FRA Major Depressive Disor-
der 
Multi-trauma (pre-
cipitation) 
Cocaine/Prescrip-
tion drug (antide-
pressant) 
12/01 M 65 SPA Insomnia Acute trauma; 
acute resp insuff 
(gunshot wound) 
- 
23/02 M 29 SPA Substance abuse Asphyxia (hanging) - 
31/03 M 32 SPA - Asphyxia (hanging) - 
06/05 M 51 SPA - Anoxia (hanging) - 
17 
16/05 M 34 SPA Major Depressive Disor-
der 
Anoxia (incomplete 
hanging) 
- 
10/06 F 28 UK Personality Disoder/sub-
stance abuse 
Anoxia (incomplete 
hanging) 
Cocaine/alcohol 
13/07 F 51 SPA Previous suicide attempt Multi-trauma (pre-
cipitation) 
- 
13/07 M 48 UK - Neurogenic shock 
(stabbing) 
- 
 
